News
SBFMW
0.0595
+12.26%
0.0065
Sunshine Biopharma receives Canadian approval for generic Arimidex
TipRanks · 3d ago
Sunshine Biopharma Announces Approval Of Generic Anastrozole Tablets Of 1mg For Canadian Market
Benzinga · 3d ago
Sunshine Biopharma wins Canadian approval for generic Arimidex tablet
PUBT · 3d ago
Weekly Report: what happened at SBFM last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at SBFM last week (0608-0612)?
Weekly Report · 06/15 09:09
Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering
PUBT · 06/08 20:07
Weekly Report: what happened at SBFM last week (0601-0605)?
Weekly Report · 06/08 09:09
Pre-Market Movers: BJDX, PMI, SBFM Drive Momentum
NASDAQ · 06/02 12:41
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Benzinga · 06/02 09:49
Sunshine Biopharma Shares Jump 66% Pre-Market After Reverse Split; Canadian OK For Rivaroxaban
NASDAQ · 06/02 09:29
Sunshine Biopharma announces Canadian approval for Rivaroxaban
TipRanks · 06/01 12:23
Sunshine Biopharma Receives Canada Approval For Its Generic Rivaroxaban Tablets
Benzinga · 06/01 12:04
Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets
PUBT · 06/01 12:02
Weekly Report: what happened at SBFM last week (0525-0529)?
Weekly Report · 06/01 09:09
Upcoming Stock Splits This Week (June 1 to June 5) – Stay Invested
TipRanks · 05/31 13:45
Sunshine Biopharma Inc trading halted, news pending
TipRanks · 05/29 23:55
Sunshine Biopharma Approves Dilutive Share and Warrant Actions
TipRanks · 05/29 20:49
Sunshine Biopharma shareholder approved discounted share issuance above 20% Nasdaq limit
PUBT · 05/29 20:10
Sunshine Biopharma files draft information statement on warrant approval provisions
PUBT · 05/29 20:09
Sunshine Biopharma issued U.S. patent for coronavirus treatment tech
TipRanks · 05/29 13:11
More
Webull provides a variety of real-time SBFMW stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFMW
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.